Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells.
Zhiguo GaoYaojia LiJiaqi XingYougong LuQuanlin ShaoJinzhong HuShan ZhaoWei HeBai-Wang SunPublished in: ACS applied materials & interfaces (2024)
Employing transition metal catalysts (TMCs) to perform bioorthogonal activation of prodrugs and pro-fluorophores in biological systems, particularly in a conditional fashion, remains a challenge. Here, we used a mesoporous organosilica nanoscaffold (RuMSN), which localizes Ru(II) conjugates on the pore wall, enabling the biorthogonal photoreduction reactions of azide groups. Due to easily adjustable surface charges and pore diameter, this efficiently engineering RuMSN catalyst, with abundant active sites on the inner pore well, could spontaneously repel or attract substrates with different molecular sizes and charges and thus ensure selective bioorthogonal catalysis. Depending on it, engineering RuMSN nanoreactors showed fascinating application scales from conditional bioorthogonal activation of prodrugs and pro-fluorophores in either intra- or extracellular localization to performing intracellular concurrent and tandem catalysis together with natural enzymes.
Keyphrases
- transition metal
- visible light
- induced apoptosis
- ionic liquid
- metal organic framework
- cell cycle arrest
- energy transfer
- room temperature
- locally advanced
- endoplasmic reticulum stress
- reactive oxygen species
- cell proliferation
- carbon dioxide
- signaling pathway
- cancer therapy
- radiation therapy
- reduced graphene oxide
- drug delivery